Meridian raises fiscal EPS guidance to up to $0.60

Cincinnati, Ohio, USA-based drugmaker Meridian Bioscience has increased its previous earnings guidance for fiscal 2007 from a range of $0.55 to $0.58 per share to a new range of $0.57 to $0.60 per share.

The firm says that the estimates assume an increase in average shares outstanding from approximately 40.2 million at fiscal 2006 year end to 40.5 million at the end of the current financial year.

Meridian's net sales guidance has also been increased from the previous range of $118.0 million to $123.0 million to a new range of between $121.0 and $124.0 million. However, the firm noted that these new projections do not include the impact of any acquisitions the company might complete during fiscal 2007.